Skip to main content
. 2018 May 8;8(30):16645–16656. doi: 10.1039/c8ra00242h

Significant altered metabolites induced by drugs that interfere with RNAa.

No. RT/min Biomarker m/z P value AUC FC Trend Metabolite pathway
1 39.952 Ribonic acid 167.0589 ***P < 0.001 0.520 1.562
2 12.269 Deoxyadenosine 274.1097 ***P < 0.001 0.875 1.646 Purine metabolism
3 12.759 5-Thymidylic acid 340.2486 **P < 0.01 0.843 6.795 Pyrimidine metabolism
4 40.002 Neryl glucoside 345.0645 **P < 0.01 0.807 0.004
5 16.917 Uracil 113.0375 **P < 0.01 0.521 1.011 Pyrimidine metabolism
6 0.675 Hypoxanthine 136.9216 ***P < 0.001 0.821 2.487 Pyrimidine metabolism
7 12.983 Isoleucine 131.9327 ***P < 0.001 0.912 3.769 Valine, leucine and isoleucine biosynthesis
8 19.790 Aspartic acid 134.0478 ***P < 0.001 0.615 0.411 Alanine, aspartate and glutamate metabolism
9 19.792 Dehydroalanine 88.0386 ***P < 0.001 0.812 1.856 Methylation metabolism
10 11.429 Dimethylglycine 104.0691 **P < 0.01 0.512 0.136 Methylation metabolism
11 15.802 N-Methyl-d-aspartic acid 148.0639 **P < 0.01 0.735 0.021
12 1.795 N-Acetyl-d-glucosamine 6-phosphate 319.0641 ***P < 0.001 0.631 0.106 Amino sugar and nucleotide sugar metabolism
a

“↑” indicates that the metabolite content in the drug-treated group is higher than that in the control group; “↓” indicates that the metabolite content in the drug-treated group is lower than that in the control group; the P value was calculated using One Way ANOVA with the Bonferroni correction (significance at *P < 0.05, **P < 0.01, ***P < 0.001); “—” means that there is no corresponding metabolite pathway determined by MetaboAnalyst 3.0.